Jianfeng Wang1, Haiyang Shen2, Tao Liu2, Qian Li2, Zhaoyang Lyu1, Youtao Yu3. 1. Department of Interventional Radiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China. 2. Department of Interventional Radiology, the Fourth Medical Center of PLA General Hospital, Beijing, China. 3. Department of Interventional Radiology, the Fourth Medical Center of PLA General Hospital, Beijing, China. yuyoutao@126.com.
Abstract
PROPOSE: To evaluate the efficacy and safety of recanalizing hyaluronic acid-occluded retinal central artery by intra-arterially infusing hyaluronidase. METHODS: Between December 2015 and December 2016, 30 patients with monocular blindness due to the injection of hyaluronic acid in facial tissue underwent ophthalmic artery recanalization. The outcome of the intra-arterial treatment was retrospectively reviewed. The fundus was examined 24 hours after the treatment to observe revisualization of the retinal arteries. The success rate of intra-arterial recanalization of the ophthalmic artery, procedure-related complications, visual acuity recovery, eyeball and eyelid movement restoration was followed up for up to 3 months. RESULTS: The success rate of ophthalmic arterial catheterization was 100%. No interventional procedure-related adverse events were found. Twenty-six patients presented ptosis and 23 patients presented ocular motility disorders. The ptosis disappeared and 18 patients had normal eye movement after the intra-arterial therapy. Five of the 30 patients had visual improvement and four patients with complete vision loss gained some light perception. After the intra-arterial thrombolysis, digital subtraction angiographic imaging revealed enlarged and numerous branches of the ophthalmic artery and a clearer ring around the eye. CONCLUSION: Intra-arterial infusion of hyaluronidase and mechanical recanalization is an effective and safe approach for recovering the visual acuity in the patients with monocular blindness caused by the migration of hyaluronic acid injected in the facial tissues. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
PROPOSE: To evaluate the efficacy and safety of recanalizing hyaluronic acid-occluded retinal central artery by intra-arterially infusing hyaluronidase. METHODS: Between December 2015 and December 2016, 30 patients with monocular blindness due to the injection of hyaluronic acid in facial tissue underwent ophthalmic artery recanalization. The outcome of the intra-arterial treatment was retrospectively reviewed. The fundus was examined 24 hours after the treatment to observe revisualization of the retinal arteries. The success rate of intra-arterial recanalization of the ophthalmic artery, procedure-related complications, visual acuity recovery, eyeball and eyelid movement restoration was followed up for up to 3 months. RESULTS: The success rate of ophthalmic arterial catheterization was 100%. No interventional procedure-related adverse events were found. Twenty-six patients presented ptosis and 23 patients presented ocular motility disorders. The ptosis disappeared and 18 patients had normal eye movement after the intra-arterial therapy. Five of the 30 patients had visual improvement and four patients with complete vision loss gained some light perception. After the intra-arterial thrombolysis, digital subtraction angiographic imaging revealed enlarged and numerous branches of the ophthalmic artery and a clearer ring around the eye. CONCLUSION: Intra-arterial infusion of hyaluronidase and mechanical recanalization is an effective and safe approach for recovering the visual acuity in the patients with monocular blindness caused by the migration of hyaluronic acid injected in the facial tissues. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Authors: Jean D A Carruthers; Steve Fagien; Rod J Rohrich; Susan Weinkle; Alastair Carruthers Journal: Plast Reconstr Surg Date: 2014-12 Impact factor: 4.730
Authors: Kwok Thye David Loh; Jun Jin Chua; Hung Ming Lee; Joyce Teng-Ee Lim; Gerard Chuah; Benjamin Yim; Boon Kwang Puah Journal: Singapore Med J Date: 2016-08 Impact factor: 1.858
Authors: Alexandra Lucaciu; Patrick Felix Samp; Elke Hattingen; Roxane-Isabelle Kestner; Petra Davidova; Thomas Kohnen; Jasmin Rudolph; Andreas Dietz; Helmuth Steinmetz; Adam Strzelczyk Journal: Neurol Res Pract Date: 2022-07-18